Logo image of BNOR.OL

BLUENORD ASA (BNOR.OL) Stock Fundamental Analysis

Europe - OSL:BNOR - NO0010379266 - Common Stock

481 NOK
+5.5 (+1.16%)
Last: 11/7/2025, 7:00:00 PM
Fundamental Rating

4

BNOR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 63 industry peers in the Oil, Gas & Consumable Fuels industry. BNOR has a medium profitability rating, but doesn't score so well on its financial health evaluation. BNOR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BNOR had negative earnings in the past year.
In the past year BNOR had a positive cash flow from operations.
In multiple years BNOR reported negative net income over the last 5 years.
Each year in the past 5 years BNOR had a positive operating cash flow.
BNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFBNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

BNOR has a Return On Assets of -0.78%. This is in the lower half of the industry: BNOR underperforms 74.60% of its industry peers.
The Return On Equity of BNOR (-3.62%) is worse than 76.19% of its industry peers.
BNOR has a Return On Invested Capital (5.61%) which is comparable to the rest of the industry.
BNOR had an Average Return On Invested Capital over the past 3 years of 9.38%. This is in line with the industry average of 9.77%.
Industry RankSector Rank
ROA -0.78%
ROE -3.62%
ROIC 5.61%
ROA(3y)0.08%
ROA(5y)-0.18%
ROE(3y)-0.58%
ROE(5y)-1.96%
ROIC(3y)9.38%
ROIC(5y)6.79%
BNOR.OL Yearly ROA, ROE, ROICBNOR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

With a decent Operating Margin value of 28.10%, BNOR is doing good in the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Operating Margin of BNOR has grown nicely.
BNOR has a Gross Margin of 56.91%. This is in the better half of the industry: BNOR outperforms 68.25% of its industry peers.
In the last couple of years the Gross Margin of BNOR has grown nicely.
Industry RankSector Rank
OM 28.1%
PM (TTM) N/A
GM 56.91%
OM growth 3Y7.98%
OM growth 5Y29.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.05%
GM growth 5Y2.78%
BNOR.OL Yearly Profit, Operating, Gross MarginsBNOR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K 4K -4K

2

2. Health

2.1 Basic Checks

BNOR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for BNOR has been increased compared to 1 year ago.
BNOR has more shares outstanding than it did 5 years ago.
BNOR has a worse debt/assets ratio than last year.
BNOR.OL Yearly Shares OutstandingBNOR.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
BNOR.OL Yearly Total Debt VS Total AssetsBNOR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

The Debt to FCF ratio of BNOR is 9.10, which is on the high side as it means it would take BNOR, 9.10 years of fcf income to pay off all of its debts.
BNOR has a Debt to FCF ratio (9.10) which is comparable to the rest of the industry.
A Debt/Equity ratio of 1.50 is on the high side and indicates that BNOR has dependencies on debt financing.
BNOR's Debt to Equity ratio of 1.50 is on the low side compared to the rest of the industry. BNOR is outperformed by 84.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF 9.1
Altman-Z N/A
ROIC/WACC0.67
WACC8.43%
BNOR.OL Yearly LT Debt VS Equity VS FCFBNOR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.41 indicates that BNOR should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.41, BNOR is in line with its industry, outperforming 57.14% of the companies in the same industry.
A Quick Ratio of 1.27 indicates that BNOR should not have too much problems paying its short term obligations.
BNOR's Quick ratio of 1.27 is fine compared to the rest of the industry. BNOR outperforms 65.08% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.27
BNOR.OL Yearly Current Assets VS Current LiabilitesBNOR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

BNOR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -560.00%.
The Revenue has grown by 9.88% in the past year. This is quite good.
The Revenue has been growing by 16.10% on average over the past years. This is quite good.
EPS 1Y (TTM)-560%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
Revenue 1Y (TTM)9.88%
Revenue growth 3Y7.52%
Revenue growth 5Y16.1%
Sales Q2Q%52.34%

3.2 Future

Based on estimates for the next years, BNOR will show a very strong growth in Earnings Per Share. The EPS will grow by 30.91% on average per year.
BNOR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.69% yearly.
EPS Next Y259.6%
EPS Next 2Y114.69%
EPS Next 3Y61.32%
EPS Next 5Y30.91%
Revenue Next Year46.12%
Revenue Next 2Y31.15%
Revenue Next 3Y17.93%
Revenue Next 5Y8.69%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BNOR.OL Yearly Revenue VS EstimatesBNOR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
BNOR.OL Yearly EPS VS EstimatesBNOR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -100 -200 -300

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BNOR. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 6.52, which indicates a rather cheap valuation of BNOR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BNOR indicates a rather cheap valuation: BNOR is cheaper than 88.89% of the companies listed in the same industry.
BNOR is valuated cheaply when we compare the Price/Forward Earnings ratio to 32.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 6.52
BNOR.OL Price Earnings VS Forward Price EarningsBNOR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BNOR is valued a bit cheaper than 63.49% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BNOR is valued cheaply inside the industry as 82.54% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.73
EV/EBITDA 5.57
BNOR.OL Per share dataBNOR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BNOR's earnings are expected to grow with 61.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y114.69%
EPS Next 3Y61.32%

0

5. Dividend

5.1 Amount

BNOR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLUENORD ASA

OSL:BNOR (11/7/2025, 7:00:00 PM)

481

+5.5 (+1.16%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)10-29 2025-10-29
Earnings (Next)02-10 2026-02-10/amc
Inst Owners39.26%
Inst Owner ChangeN/A
Ins Owners1.13%
Ins Owner ChangeN/A
Market Cap12.75B
Revenue(TTM)794.40M
Net Income(TTM)-27.70M
Analysts78.57
Price Target557.94 (16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-62.89%
Min EPS beat(2)-71.31%
Max EPS beat(2)-54.48%
EPS beat(4)0
Avg EPS beat(4)-147.45%
Min EPS beat(4)-415.9%
Max EPS beat(4)-48.1%
EPS beat(8)0
Avg EPS beat(8)-120.71%
EPS beat(12)3
Avg EPS beat(12)-79.82%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.71%
Min Revenue beat(2)-33.43%
Max Revenue beat(2)-1.98%
Revenue beat(4)0
Avg Revenue beat(4)-14.09%
Min Revenue beat(4)-33.43%
Max Revenue beat(4)-1.98%
Revenue beat(8)2
Avg Revenue beat(8)-7.17%
Revenue beat(12)4
Avg Revenue beat(12)-4.24%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.08%
PT rev (3m)-14.55%
EPS NQ rev (1m)-11.4%
EPS NQ rev (3m)-35.96%
EPS NY rev (1m)0%
EPS NY rev (3m)-47.3%
Revenue NQ rev (1m)-4.43%
Revenue NQ rev (3m)-9.65%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.52
P/S 1.58
P/FCF 7.73
P/OCF 4.1
P/B 1.64
P/tB 2.01
EV/EBITDA 5.57
EPS(TTM)-14.03
EYN/A
EPS(NY)73.76
Fwd EY15.33%
FCF(TTM)62.2
FCFY12.93%
OCF(TTM)117.41
OCFY24.41%
SpS304.8
BVpS293.29
TBVpS239.35
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.78%
ROE -3.62%
ROCE 7.28%
ROIC 5.61%
ROICexc 6.57%
ROICexgc 6.94%
OM 28.1%
PM (TTM) N/A
GM 56.91%
FCFM 20.41%
ROA(3y)0.08%
ROA(5y)-0.18%
ROE(3y)-0.58%
ROE(5y)-1.96%
ROIC(3y)9.38%
ROIC(5y)6.79%
ROICexc(3y)10.23%
ROICexc(5y)7.37%
ROICexgc(3y)10.87%
ROICexgc(5y)7.85%
ROCE(3y)12.19%
ROCE(5y)8.82%
ROICexgc growth 3Y15.21%
ROICexgc growth 5Y43.84%
ROICexc growth 3Y15.53%
ROICexc growth 5Y45.83%
OM growth 3Y7.98%
OM growth 5Y29.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.05%
GM growth 5Y2.78%
F-Score5
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF 9.1
Debt/EBITDA 2.81
Cap/Depr 78.38%
Cap/Sales 18.11%
Interest Coverage 1.94
Cash Conversion 75.22%
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 1.27
Altman-Z N/A
F-Score5
WACC8.43%
ROIC/WACC0.67
Cap/Depr(3y)220.14%
Cap/Depr(5y)197.46%
Cap/Sales(3y)32.67%
Cap/Sales(5y)36.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-560%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
EPS Next Y259.6%
EPS Next 2Y114.69%
EPS Next 3Y61.32%
EPS Next 5Y30.91%
Revenue 1Y (TTM)9.88%
Revenue growth 3Y7.52%
Revenue growth 5Y16.1%
Sales Q2Q%52.34%
Revenue Next Year46.12%
Revenue Next 2Y31.15%
Revenue Next 3Y17.93%
Revenue Next 5Y8.69%
EBIT growth 1Y-10.29%
EBIT growth 3Y16.1%
EBIT growth 5Y50.9%
EBIT Next Year195.77%
EBIT Next 3Y50.93%
EBIT Next 5Y23.2%
FCF growth 1Y-30.87%
FCF growth 3YN/A
FCF growth 5Y-14.92%
OCF growth 1Y-39.47%
OCF growth 3Y84.65%
OCF growth 5Y4.46%

BLUENORD ASA / BNOR.OL FAQ

What is the ChartMill fundamental rating of BLUENORD ASA (BNOR.OL) stock?

ChartMill assigns a fundamental rating of 4 / 10 to BNOR.OL.


Can you provide the valuation status for BLUENORD ASA?

ChartMill assigns a valuation rating of 6 / 10 to BLUENORD ASA (BNOR.OL). This can be considered as Fairly Valued.


How profitable is BLUENORD ASA (BNOR.OL) stock?

BLUENORD ASA (BNOR.OL) has a profitability rating of 4 / 10.


Can you provide the financial health for BNOR stock?

The financial health rating of BLUENORD ASA (BNOR.OL) is 2 / 10.